Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network

Acosta, 2008, Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence, Cell, 133, 1006, 10.1016/j.cell.2008.03.038 Adams, 2007, Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging, Gene, 397, 84, 10.1016/j.gene.2007.04.020 Ancrile, 2007, Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis, Genes Dev., 21, 1714, 10.1101/gad.1549407 Bartkova, 2006, Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints, Nature, 444, 633, 10.1038/nature05268 Beausejour, 2003, Reversal of human cellular senescence: Roles of the p53 and p16 pathways, EMBO J., 22, 4212, 10.1093/emboj/cdg417 Berns, 2004, A large-scale RNAi screen in human cells identifies new components of the p53 pathway, Nature, 428, 431, 10.1038/nature02371 Braig, 2005, Oncogene-induced senescence as an initial barrier in lymphoma development, Nature, 436, 660, 10.1038/nature03841 Brakenhoff, 1994, Development of a human interleukin-6 receptor antagonist, J. Biol. Chem., 269, 86, 10.1016/S0021-9258(17)42317-9 Campisi, 2005, Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors, Cell, 120, 513, 10.1016/j.cell.2005.02.003 Chen, 2005, Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis, Nature, 436, 725, 10.1038/nature03918 Collado, 2005, Tumour biology: Senescence in premalignant tumours, Nature, 436, 642, 10.1038/436642a Courtois-Cox, 2006, A negative feedback signaling network underlies oncogene-induced senescence, Cancer Cell, 10, 459, 10.1016/j.ccr.2006.10.003 Dai, 2000, p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation, Gastroenterology, 119, 929, 10.1053/gast.2000.17952 Dankort, 2007, A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors, Genes Dev., 21, 379, 10.1101/gad.1516407 Davies, 2002, Mutations of the BRAF gene in human cancer, Nature, 417, 949, 10.1038/nature00766 Denoyelle, 2006, Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway, Nat. Cell Biol., 8, 1053, 10.1038/ncb1471 Di Micco, 2006, Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication, Nature, 444, 638, 10.1038/nature05327 Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc. Natl. Acad. Sci. USA, 92, 9363, 10.1073/pnas.92.20.9363 Dirac, 2003, Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53, J. Biol. Chem., 278, 11731, 10.1074/jbc.C300023200 Finkel, 2007, The common biology of cancer and ageing, Nature, 448, 767, 10.1038/nature05985 Garnett, 2004, Guilty as charged: B-RAF is a human oncogene, Cancer Cell, 6, 313, 10.1016/j.ccr.2004.09.022 Gomis, 2006, C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells, Cancer Cell, 10, 203, 10.1016/j.ccr.2006.07.019 Gray-Schopfer, 2006, Cellular senescence in naevi and immortalisation in melanoma: A role for p16?, Br. J. Cancer, 95, 496, 10.1038/sj.bjc.6603283 Ha, 2007, ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence, Proc. Natl. Acad. Sci. USA, 104, 10968, 10.1073/pnas.0611638104 Hirano, 1989, Interleukin-6: Possible implications in human diseases, Ric. Clin. Lab., 19, 1, 10.1007/BF02871787 Hodge, 2001, Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells, J. Biol. Chem., 276, 39508, 10.1074/jbc.C100343200 Hong, 2007, Interleukin-6 and its receptor in cancer: Implications for Translational Therapeutics, Cancer, 110, 1911, 10.1002/cncr.22999 Kalai, 1997, Analysis of the mechanism of action of anti-human interleukin-6 and anti-human interleukin-6 receptor-neutralising monoclonal antibodies, Eur. J. Biochem., 249, 690, 10.1111/j.1432-1033.1997.t01-2-00690.x Kortlever, 2006, Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence, Nat. Cell Biol., 8, 877, 10.1038/ncb1448 Krimpenfort, 2007, p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a, Nature, 448, 943, 10.1038/nature06084 Krtolica, 2001, Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging, Proc. Natl. Acad. Sci. USA, 98, 12072, 10.1073/pnas.211053698 Lloyd, 1997, Cooperating oncogenes converge to regulate cyclin/cdk complexes, Genes Dev., 11, 663, 10.1101/gad.11.5.663 Lowe, 2004, Intrinsic tumour suppression, Nature, 432, 307, 10.1038/nature03098 Lu, 1993, Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression, J. Cell Biol., 120, 1281, 10.1083/jcb.120.5.1281 Mallette, 2007, The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence, Genes Dev., 21, 43, 10.1101/gad.1487307 Mason, 2004, Molecular signature of oncogenic ras-induced senescence, Oncogene, 23, 9238, 10.1038/sj.onc.1208172 Michaloglou, 2005, BRAFE600-associated senescence-like cell cycle arrest of human naevi, Nature, 436, 720, 10.1038/nature03890 Mooi, 2006, Oncogene-induced cell senescence–halting on the road to cancer, N. Engl. J. Med., 355, 1037, 10.1056/NEJMra062285 Narita, 2003, Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence, Cell, 113, 703, 10.1016/S0092-8674(03)00401-X Nicke, 2005, Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells, Mol. Cell, 20, 673, 10.1016/j.molcel.2005.10.038 Peeper, 2002, A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence, Nat. Cell Biol., 4, 148, 10.1038/ncb742 Ramji, 2002, CCAAT/enhancer-binding proteins: Structure, function and regulation, Biochem. J., 365, 561, 10.1042/bj20020508 Rowland, 2005, The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene, Nat. Cell Biol., 7, 1074, 10.1038/ncb1314 Sage, 2003, Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry, Nature, 424, 223, 10.1038/nature01764 Schnabl, 2003, Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype, Hepatology, 37, 653, 10.1053/jhep.2003.50097 Sebastian, 2005, C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence, EMBO J., 24, 3301, 10.1038/sj.emboj.7600789 Shay, 2005, Senescence and immortalization: Role of telomeres and telomerase, Carcinogenesis, 26, 867, 10.1093/carcin/bgh296 Sherr, 2004, Principles of tumor suppression, Cell, 116, 235, 10.1016/S0092-8674(03)01075-4 Sparmann, 2004, Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis, Cancer Cell, 6, 447, 10.1016/j.ccr.2004.09.028 Tremain, 2000, Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras, Oncogene, 19, 1698, 10.1038/sj.onc.1203471 Xue, 2007, Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas, Nature, 445, 656, 10.1038/nature05529 Ye, 2007, Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells, Mol. Cell, 27, 183, 10.1016/j.molcel.2007.05.034